genomic health inc (GHDX:NASDAQ GS)
Transactions by GENOMIC HEALTH INC (GHDX) in the last 6 months
InVitae Corporation announced that it has received $120 million in its series F round of funding on October 13, 2014. The round included participation from new investors, including The Broe Group, Investment Arm, Decheng Capital, Deerfield Management LLC, OrbiMed, Perceptive Advisors LLC, Rock Springs Capital Management LP, Wellington Management Company, LLP, and other investors. Existing investors, including Casdin Capital, Genesys Capital, Genomic Health, Inc., Randy ...
Decheng Capital LLC
Deerfield Capital Management, LLC
Genesys Capital Partners Inc.
Genomic Health Inc.
OrbiMed Advisors, L.L.C.
Perceptive Advisors LLC
Redmile Group, LLC
Rock Springs Capital Management LP
The Broe Group, Investment Arm
Thomas, McNerney & Partners
Wellington Management Company, LLP
|Alliance HealthCare Services Inc||$24.32 USD||+0.41|
|Enzo Biochem Inc||$3.42 USD||-0.07|
|Foundation Medicine Inc||$47.04 USD||-0.22|
|NanoString Technologies Inc||$12.86 USD||-0.16|
|NeoGenomics Inc||$3.93 USD||+0.04|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|